Here are relevant reports on : automotive-diagnostic-market
-
Ambulance Equipment Market by Type (Transportation, Burn Care, Diagnostic and Infection Control, Blood and Hemorrhage Control, Respiratory, Hypothermia, Cardiac Equipment), by End User (Air Ambulance, Water Ambulance, Ground Ambulance) - Forecast to 2023
The global ambulance equipment market was valued at USD 4.31 Billion in 2017, and is expected to witness a CAGR of 3.3% over the forecast period (2018 – 2026). Ambulance equipment is a type of equipment used to aid patients at the time of medical emergencies, including accidents and surgeries, thus helping minimize personal injuries and preventing loss of life. Advancements in healthcare technology along with increasing patient inclination towards faster and efficient mode of delivery are some of the major factors driving the growth of the global ambulance equipment market. Rising number of emergency cases is another major factor that is expected to enhance growth of the ambulance equipment market during the forecast period.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Asia Pacific biomarkers market is projected to reach USD 26.40 billion by 2030 from USD 14.73 billion in 2025, at a CAGR of 12.4% during the forecast period. The Key players include Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), QIAGEN (Germany), JSR Corporation (Japan), WuXi AppTec (China), among others.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Industrial Analytics Market by Component (Software, Service), Analytics Type (Descriptive, Diagnostic, Predictive, and Prescriptive), Deployment Model, organization size, Industry Vertical, and Region - Global Forecast to 2022
The industrial analytics market is expected to grow from USD 11.29 Billion in 2017 to USD 25.51 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 17.7%. The report also encompasses different strategies, such as acquisitions, partnerships & collaborations, and product developments, adopted by major players to increase their share in the market. Major technology vendors in the industrial analytics market include General Electric (US), IBM Corporation (US), Microsoft Corporation (US), Oracle Corporation (US), PTC, Inc. (US), SAS Institute (US), SAP SE (Germany), Cisco Systems, Inc. (US), HPE (US), Intel Corporation (US), Hitachi, Ltd. (Japan), TIBCO Software, Inc. (US), AGT International (Switzerland), Bridgei2i Analytics Solutions (India), and Alteryx, Inc. (US).
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Rigid Endoscopes Market by Type (Laparoscopes, Arthroscopes, Cystoscopes), Clinical Usage (Diagnostic, Surgical), Application (Laparoscopy, Cystoscopy, Arthroscopy, Other), End User (Hospitals, ASCs, Clinics), Region - Global Forecast to 2030
The global rigid endoscopes market, valued at US$1.76 billion in 2024, stood at US$1.83 billion in 2025 and is projected to advance at a resilient CAGR of 4.9% from 2025 to 2030, culminating in a forecasted valuation of US$2.32 billion by the end of the period. The growth of the rigid endoscopes market is driven by increasing procedural volumes resulting from the rise in chronic pulmonary and urological conditions, as well as growing patient preference for minimally invasive diagnostics
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Ultrasound Market by Diagnostic Ultrasound (2D, 3D, 4D, Doppler), Therapeutic Ultrasound (HIFU, ESWL), Products (Cart/Trolley-Based, Compact), Applications (OB/GYN, Cardiac Ultrasound, Vascular Ultrasound, Surgical Ultrasound) - Global Forecast to 2019
The global ultrasound market is estimated to grow at a CAGR of 5.1% in the forecast period. Development of technologically advanced ultrasound devices, rapid growth in aging population with high risk of target diseases, growing demand for minimally invasive treatment procedures, and increasing public-private investments are key factors fuelling the growth of the ultrasound market.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Positron Emission Tomography Market by Product (Standalone PET Systems, PET/CT Systems, PET/MRI Systems), Application (Oncology, Cardiology, Neurology), End User (Hospitals & Surgical Centers, Diagnostic & Imaging Clinics) & Region - Global Forecasts to 2028
The global positron emission tomography market, valued at US$2.3 billion in 2022, stood at US$2.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$3.5 billion by the end of the period. Technological advancements and new product launches in the radiopharmaceuticals and PET systems, coupled with a growing target patient population, are the key factors driving the adoption of PET systems globally.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Cell Culture Reagents Market by Type (Growth Factors, Supplements, Cell Dissociation Reagents, Buffers & Chemicals, Others), Application (mAbs, Vaccines, CGT), End User (Pharma Biotech, Diagnostic Labs, Academia, Others), Region - Global Forecast to 2030
The cell culture reagents market is projected to reach USD 8.95 billion by 2030 from USD 5.05 billion in 2025, at a CAGR of 12.1% during the forecast period of 2025 to 2030. The Key Players include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), and Sartorius AG (Germany)
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Microarray Analysis Market by Product & Service (Consumables, Instrument, Software, Services), Type (DNA, Protein Microarray), Application (Research), End User (Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2023
The global microarray analysis market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.6%. The major factors driving the growth of this market are the increasing incidence of cancer, increasing funding for genomic and proteomic research, and growing application areas of microarrays. Key players in the microarray analysis market include Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Molecular Devices (US), PerkinElmer Inc. (US), Illumina, Inc. (US), GE Healthcare (US), and Bio-Rad Laboratories Inc. (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Test Strips Market by Product Type (Blood test strip, Urine Test Strip), Application (Diabetes, Infectious Disease, Cardiac Marker Testing), End-use (Hospitals, Home Care, Diagnostic Laboratories) - Global Forecast to 2027
The global test strips market is projected to reach USD 12.9 billion by 2027 from USD 11.4 billion in 2021, at a CAGR of 2.1% during the forecast period . The growth of test strips market is owing to Increasing prevalence of diabetes across the globe, rising preference for point of care testing, and increasing technological advancements in test strips whereas the low accuracy of test strips are restraining this market up to certain extent.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious), Application (Diagnostic, Research)- Forecast to 2030
The Europe biomarkers market is projected to reach USD 28.11 billion by 2030 from USD 17.46 billion in 2025, at a CAGR of 10.0% during the forecast period. The Key Players include F. Hoffmann-La Roche Ltd (Switzerland), Merck KGaA (Germany), QIAGEN (Germany), Eurofins Scientific (Luxembourg), bioMérieux (France), R-Biopharm AG (Germany), Synexa Life Sciences BV (Netherlands), Proteome Sciences (UK).
- Published: February 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
